Chan Zuckerberg Biohub Announces First Class of Investigators

Mark Zuckerberg: Our team at the Biohub just funded its first class of investigators — 47 scientists from StanfordUCSF and Berkeley working to help cure all diseases in our children’s lifetime.

Today, just four kinds of diseases cause the majority of deaths. The Chan Zuckerberg Initiative is focused on bringing scientists and engineers together to build technology to make progress on all of them.

We’re investing $50 million in this first class of investigators. This program will provide 5 years of funding to some of the most innovative researchers in the Bay Area, especially focused on young scientists early in their careers.

This first group includes a Stanford data scientist working to analyze massive quantities of genomic data, a doctor from UCSF looking at how malaria spreads, an engineer from Berkeley who is designing tools to better understand human biology, including a miniature foldable microscope, and more. This is a diverse group, with almost 50% women and 15% underrepresented minorities.

Thanks to everyone who applied for this program, and to Biohub leaders Joe DeRisi and Steve Quake for choosing such an amazing group. I’m excited to see what they come up with.

News

  • GEN: Virtual Cells Go Multiscale to Predict Complex Biology

    AI models inform therapeutics that can restore diseased cells to healthy states

  • Protein Modeling, Cell Imaging and Patient-Powered Science: Reflections on Biohub’s Start to the Year

    Co-founder Priscilla Chan shares reflections following Aspen Ideas: Health on the models, tools, and people driving Biohub's progress this year.

  • Surprising drug targets for psoriasis emerge from comprehensive CRISPR study of human skin cells

    Analysis of results by AI ‘novelty filter’ led researchers to formulate topical gels that, in mice, were as effective as widely used injected therapy.